Pim1 maintains telomere length in mouse cardiomyocytes by inhibiting TGFβ signalling.
A549 Cells
Animals
Cellular Senescence
/ drug effects
Humans
Male
Mice, Knockout
Myocytes, Cardiac
/ drug effects
Phosphorylation
Proto-Oncogene Proteins c-pim-1
/ genetics
Receptors, Transforming Growth Factor beta
/ metabolism
Signal Transduction
Smad2 Protein
/ metabolism
Smad3 Protein
/ metabolism
Telomerase
/ metabolism
Telomere Homeostasis
/ drug effects
Transforming Growth Factor beta1
/ pharmacology
Cardiomyocyte
Pim1
Smad2
TGFβ
Telomere
Journal
Cardiovascular research
ISSN: 1755-3245
Titre abrégé: Cardiovasc Res
Pays: England
ID NLM: 0077427
Informations de publication
Date de publication:
01 01 2021
01 01 2021
Historique:
received:
30
07
2019
accepted:
13
03
2019
pubmed:
17
3
2020
medline:
7
10
2021
entrez:
17
3
2020
Statut:
ppublish
Résumé
Telomere attrition in cardiomyocytes is associated with decreased contractility, cellular senescence, and up-regulation of proapoptotic transcription factors. Pim1 is a cardioprotective kinase that antagonizes the aging phenotype of cardiomyocytes and delays cellular senescence by maintaining telomere length, but the mechanism remains unknown. Another pathway responsible for regulating telomere length is the transforming growth factor beta (TGFβ) signalling pathway where inhibiting TGFβ signalling maintains telomere length. The relationship between Pim1 and TGFβ has not been explored. This study delineates the mechanism of telomere length regulation by the interplay between Pim1 and components of TGFβ signalling pathways in proliferating A549 cells and post-mitotic cardiomyocytes. Telomere length was maintained by lentiviral-mediated overexpression of PIM1 and inhibition of TGFβ signalling in A549 cells. Telomere length maintenance was further demonstrated in isolated cardiomyocytes from mice with cardiac-specific overexpression of PIM1 and by pharmacological inhibition of TGFβ signalling. Mechanistically, Pim1 inhibited phosphorylation of Smad2, preventing its translocation into the nucleus and repressing expression of TGFβ pathway genes. Pim1 maintains telomere lengths in cardiomyocytes by inhibiting phosphorylation of the TGFβ pathway downstream effectors Smad2 and Smad3, which prevents repression of telomerase reverse transcriptase. Findings from this study demonstrate a novel mechanism of telomere length maintenance and provide a potential target for preserving cardiac function.
Identifiants
pubmed: 32176281
pii: 5807612
doi: 10.1093/cvr/cvaa066
pmc: PMC7797214
doi:
Substances chimiques
Receptors, Transforming Growth Factor beta
0
Smad2 Protein
0
Smad2 protein, mouse
0
Smad3 Protein
0
Smad3 protein, mouse
0
Transforming Growth Factor beta1
0
PIM1 protein, human
EC 2.7.11.1
Pim1 protein, mouse
EC 2.7.11.1
Proto-Oncogene Proteins c-pim-1
EC 2.7.11.1
Telomerase
EC 2.7.7.49
Tert protein, mouse
EC 2.7.7.49
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
201-211Subventions
Organisme : American Heart Association-American Stroke Association
ID : 18PRE33990268
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.
Références
EMBO J. 2003 Jan 2;22(1):131-9
pubmed: 12505991
Int J Mol Sci. 2018 Jan 19;19(1):
pubmed: 29351238
Nat Cell Biol. 2004 Apr;6(4):366-72
pubmed: 15104092
Nat Rev Genet. 2005 Aug;6(8):611-22
pubmed: 16136653
J Am Coll Cardiol. 2012 Oct 2;60(14):1278-87
pubmed: 22841153
Biochem Biophys Res Commun. 1999 Feb 5;255(1):110-5
pubmed: 10082664
J Clin Invest. 2013 Mar;123(3):996-1002
pubmed: 23454763
PLoS One. 2015 Jun 25;10(6):e0130707
pubmed: 26110811
J Mol Cell Cardiol. 2011 Oct;51(4):600-6
pubmed: 21059352
Circulation. 2009 Nov 24;120(21):2077-87
pubmed: 19901187
Expert Rev Cardiovasc Ther. 2009 Aug;7(8):929-38
pubmed: 19673671
Genes (Basel). 2016 Sep 01;7(9):
pubmed: 27598203
Microbes Infect. 1999 Dec;1(15):1255-63
pubmed: 10611753
Cardiovasc Res. 2009 Feb 1;81(2):244-52
pubmed: 19047341
Nat Cell Biol. 2013 Aug;15(8):895-904
pubmed: 23831727
Circ Res. 2010 Apr 16;106(7):1265-74
pubmed: 20203306
Nucleic Acids Res. 2009 Feb;37(3):e21
pubmed: 19129229
Cell. 2003 Jun 13;113(6):685-700
pubmed: 12809600
Nucleic Acids Res. 2000 Nov 15;28(22):4474-8
pubmed: 11071935
Stem Cells. 2012 Nov;30(11):2512-22
pubmed: 22915504
BMC Cell Biol. 2006 Jan 10;7:1
pubmed: 16403219
Nat Med. 2007 Dec;13(12):1467-75
pubmed: 18037896
Protein Cell. 2017 Jan;8(1):39-54
pubmed: 27696331
Mol Cancer Res. 2007 Sep;5(9):909-22
pubmed: 17855660
Nat Cell Biol. 2004 Apr;6(4):358-65
pubmed: 15048128
J Biol Chem. 2006 Sep 1;281(35):25588-600
pubmed: 16785237
Circ Res. 2014 Jul 18;115(3):376-87
pubmed: 24916111
JCI Insight. 2019 Jan 10;4(1):
pubmed: 30626739
EMBO J. 2009 Sep 2;28(17):2532-40
pubmed: 19629041
Cell Growth Differ. 2001 Feb;12(2):119-27
pubmed: 11243466
Cell Signal. 2008 Jan;20(1):50-9
pubmed: 17881189
J Am Heart Assoc. 2017 Sep 7;6(9):
pubmed: 28882819
J Biol Chem. 1999 Jun 25;274(26):18659-66
pubmed: 10373478
Oncol Rep. 2008 Sep;20(3):619-24
pubmed: 18695914
Cancer Biol Ther. 2008 Sep;7(9):1352-9
pubmed: 18708761
Cell Death Dis. 2018 Feb 22;9(3):307
pubmed: 29472550
Physiol Genomics. 2017 Jul 1;49(7):368-384
pubmed: 28550088
Circ Res. 2013 Oct 25;113(10):1169-79
pubmed: 24044948
J Am Coll Cardiol. 2015 Jan 20;65(2):133-47
pubmed: 25593054
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):13889-94
pubmed: 18784362